Sign In
Buy AEMD
$1.36
-0.0200 (-1.45%)
At Close: Jun 23, 2026
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
07:32pm, Wednesday, 10'th Jun 2026
Aethlon Medical, Inc. (AEMD) Q4 2026 Earnings Call Transcript
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
04:15pm, Wednesday, 10'th Jun 2026
Australian oncology study advances into Cohort 3 as enrollment continues Entered the third and final dosing cohort of the Australian oncology study, expanded the Hemopurifier intellectual property por
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
08:01am, Tuesday, 02'nd Jun 2026
SAN DIEGO, June 2, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, to
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
08:01am, Thursday, 21'st May 2026
SAN DIEGO, May 21, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, tod
Advancements in Novel Immunotherapeutics in The Oncology Battle
10:30am, Tuesday, 24'th Mar 2026
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - March 24, 2026) - Investorideas.com, a go-to investing platform, releases an industry
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
08:01am, Tuesday, 24'th Mar 2026
SAN DIEGO, March 24, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon Hemopurifier®, an extracorporeal device
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
08:01am, Thursday, 12'th Mar 2026
SAN DIEGO, March 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-thre
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
08:35am, Friday, 06'th Mar 2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in the life sciences sector, to attend live, interactive presentations at VirtualInvestorC
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
08:01am, Monday, 23'rd Feb 2026
Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference. SAN DIEGO, Feb. 23, 2026 /
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript
12:25pm, Thursday, 19'th Feb 2026
Aethlon Medical, Inc. (AEMD) Shareholder/Analyst Call Prepared Remarks Transcript
Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript
10:14pm, Thursday, 12'th Feb 2026
Aethlon Medical, Inc. (AEMD) Q3 2026 Earnings Call Transcript
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
04:15pm, Thursday, 12'th Feb 2026
Clinical and research programs continue to advance, supported by year-to-date cost efficiencies Conference Call Today at 4:30 p.m. ET SAN DIEGO, Feb. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (th
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
08:01am, Wednesday, 04'th Feb 2026
SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, tod
Aethlon Medical (NASDAQ:AEMD) Shares Pass Below 200-Day Moving Average – Should You Sell?
05:12am, Wednesday, 24'th Dec 2025
Aethlon Medical, Inc. (NASDAQ: AEMD - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $9.40 and traded as lo
Aethlon Medical (NASDAQ:AEMD) Stock Crosses Below 200-Day Moving Average – Here’s Why
05:31am, Tuesday, 16'th Dec 2025
Aethlon Medical, Inc. (NASDAQ: AEMD - Get Free Report)'s share price crossed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $10.46
